You say Zantac, I say Xanax: a critique of drug trademark approval and proposals for reform.
Gentin
D A
DA
D017277:Drug Approval; D006077:Government Agencies; D018166:Health Care Reform; D006801:Humans; D019451:Information Management / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011356:Product Labeling / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration